July 26, 2016 1:00 PM ET

Biotechnology

Company Overview of Grifols Therapeutics, Inc.

Executive Profile

Thomas J. Lynch Jr., J.D., M.D., Ph.D.

Senior Vice President of Corporate Compliance & Regulatory Affairs, Grifols Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 0 Board Members in 0 different organizations across 3 different industries.

55--

Background

Dr. Thomas J. Lynch, also known as Tom, Jr., J.D., M.D., Ph.D. served as Senior Vice President of Corporate Compliance Regulatory & Public Policy of Talecris Biotherapeutics Holdings Corp., and its subsidiary Talecris Biotherapeutics, Inc. since 2006. Dr. Lynch served as Vice President, Corporate Governance and Compliance of Talecris BioTherapeutics Inc. since April 2005 and Talecris Biotherapeutics Holdings Corporation. From August 19, 2003 to 2005, Dr. Lynch served ...

Corporate Headquarters

79 T.W. Alexander Drive
Research Triangle Park, North Carolina 27709

United States

Phone: 919-316-6300
Fax: 919-316-6316

Board Members Memberships

There is no Board Members Memberships data available.

Education

MD
Yale University
JD
Georgetown University
PhD
Wayne State University
Master's Degree
Clark University
BA
American International College Inc

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. Bloomberg.com does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Grifols Therapeutics, Inc., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.